About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

First Biomarker for Prostate Cancer Discovered

by Medindia Content Team on August 15, 2007 at 4:25 PM
Font : A-A+

First Biomarker for Prostate Cancer Discovered

Mayo Clinic researchers have discovered the first immune molecule that plays a role in the development of prostate cancer, besides predicting cancer recurrence and progression of the disease after surgery.

A report on the B7-H3 molecule has been published in the journal Cancer Research.

Advertisement

"This discovery will allow physicians to individualize treatment and observation plans for prostate cancer patients. Being able to tell a patient his specific risk after surgery, and perhaps even prior to surgery, will be a huge step forward," says Dr. Timothy Roth, a Mayo Clinic urology resident and lead author of the study.

The new study attains significance because there were no strongly predictive molecules for prostate cancer to date. It shows that almost all normal, pre-malignant and cancerous prostate cells have B7-H3 on their surface.
Advertisement

Since the molecule stays attached to the surface of prostate cancer cells and does not migrate, it is being considered an attractive target for therapy.

The researchers believe that B7-H3 kills or paralyses immune cells that try to attack the cancer.

The researchers examined tissue from 338 consecutive patients who had cancers confined to the prostate and were treated exclusively with a radical prostatectomy (surgery to remove the prostate) between 1995 and 1998. All tumours and pre-cancerous tissues displayed B7-H3.

It was found that patients with the highest levels of B7-H3 within their prostate tumours (19.8 per cent) were four times more likely to experience cancer progression in comparison with those with weak levels of B7-H3 within their tumours. Moderate levels of B7-H3 also correlated with a slightly higher risk of recurrence (35 per cent).

"Because B7-H3 is present in all prostate cancer tumors, and marked levels predict recurrence, we are able to forecast with much greater certainty the likelihood of cancer progression, regardless of therapeutic intervention," says Dr. Eugene Kwon, a senior investigator and urologist at Mayo Clinic.

A 'watchful waiting' clinical approach is sometimes used to manage prostate cancer for some patients, prior to resorting to therapy to see if the cancer becomes increasingly aggressive.

The researchers say that the evaluation of B7-H3 levels in prostate biopsies may soon help to determine which patients may benefit from a watchful waiting strategy.

"This is the way of the future," says Dr. Kwon, "We are becoming educated about ways to flesh out the molecular signatures of each patient's cancer. Using such molecular signatures will facilitate, for the first time, a truly individualized approach to prescribing the most appropriate therapy for a given patient. We will soon be able to tailor-make therapies for each person's cancer."

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Cancer Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] Nutrition All Men Need Common Lifestyle Habits that Cause Diseases 

Recommended Reading
Broccoli and Cauliflower Slash Prostate Cancer Risks By Half
A new study says that eating cauliflower and broccoli twice a week, can almost halve a man's ......
Prostate Cancer - Animation
Interactive section of Medindia gives details regarding Prostate Cancer...
Hormone Drugs may Offer Cure for Prostate Cancer Patients
Patients with prostate cancer may now rely upon hormone therapy, which is supported by UK ......
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Nutrition All Men Need
Everyone requires good nutrition, be it man, woman, child or elderly. However, nutrition that men ne...
Prostate Cancer
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can h...
Prostate Cancer: Treatment Options
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemothe...
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commo...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use